Michael Goldencrown v. HHS - Tdap, Guillain-Barré syndrome and/or acute disseminated encephalomyelitis (2022)

Michael Goldencrown filed a petition on January 19, 2022, seeking compensation for Guillain-Barré syndrome (GBS) and/or acute disseminated encephalomyelitis (ADEM) allegedly caused by Tdap and PCV13 vaccinations he received on February 13, 2018. Respondent denied that the vaccines caused his conditions.

However, both parties entered into a stipulation to settle the case, agreeing that a decision should be entered awarding compensation. The court reviewed the stipulation and found it reasonable, adopting it as its decision.

The award includes a lump sum of $160,680.00 for first-year life care expenses and pain and suffering. The remainder of the damages will be paid as an annuity of $10,680.00 annually for the rest of Mr.

Goldencrown's life, with a three percent annual increase. The court ordered the respondent to purchase the annuity contract from a qualified life insurance company.

Judgment was to be entered unless a motion for review was filed.